Utah Medical Products Price to Sales Ratio 2010-2024 | UTMD
Historical PS ratio values for Utah Medical Products (UTMD) over the last 10 years. The current P/S ratio for Utah Medical Products as of January 21, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Utah Medical Products P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-01-17 | 62.16 | 5.03 | |
| 2024-09-30 | 66.59 | $12.35 | 5.39 |
| 2024-06-30 | 66.19 | $12.91 | 5.13 |
| 2024-03-31 | 70.13 | $13.50 | 5.20 |
| 2023-12-31 | 82.71 | $13.81 | 5.99 |
| 2023-09-30 | 84.16 | $14.14 | 5.95 |
| 2023-06-30 | 90.89 | $14.27 | 6.37 |
| 2023-03-31 | 92.13 | $14.41 | 6.39 |
| 2022-12-31 | 97.43 | $14.33 | 6.80 |
| 2022-09-30 | 82.43 | $14.13 | 5.83 |
| 2022-06-30 | 82.72 | $14.01 | 5.91 |
| 2022-03-31 | 86.24 | $13.78 | 6.26 |
| 2021-12-31 | 95.66 | $13.41 | 7.13 |
| 2021-09-30 | 87.19 | $13.16 | 6.63 |
| 2021-06-30 | 79.61 | $12.59 | 6.32 |
| 2021-03-31 | 80.80 | $11.54 | 7.00 |
| 2020-12-31 | 78.41 | $11.47 | 6.84 |
| 2020-09-30 | 74.05 | $11.36 | 6.52 |
| 2020-06-30 | 81.88 | $11.84 | 6.92 |
| 2020-03-31 | 86.65 | $12.61 | 6.87 |
| 2019-12-31 | 99.09 | $12.55 | 7.90 |
| 2019-09-30 | 87.79 | $11.99 | 7.32 |
| 2019-06-30 | 87.42 | $11.41 | 7.66 |
| 2019-03-31 | 80.34 | $11.16 | 7.20 |
| 2018-12-31 | 75.39 | $11.20 | 6.73 |
| 2018-09-30 | 85.21 | $11.32 | 7.52 |
| 2018-06-30 | 99.35 | $11.26 | 8.82 |
| 2018-03-31 | 88.93 | $11.24 | 7.91 |
| 2017-12-31 | 73.03 | $11.09 | 6.58 |
| 2017-09-30 | 65.76 | $10.71 | 6.14 |
| 2017-06-30 | 64.50 | $10.56 | 6.11 |
| 2017-03-31 | 55.29 | $10.44 | 5.30 |
| 2016-12-31 | 64.29 | $10.42 | 6.17 |
| 2016-09-30 | 52.64 | $10.61 | 4.96 |
| 2016-06-30 | 55.23 | $10.69 | 5.17 |
| 2016-03-31 | 54.60 | $10.67 | 5.12 |
| 2015-12-31 | 50.90 | $10.65 | 4.78 |
| 2015-09-30 | 46.62 | $10.82 | 4.31 |
| 2015-06-30 | 51.35 | $11.03 | 4.66 |
| 2015-03-31 | 51.32 | $11.05 | 4.64 |
| 2014-12-31 | 51.27 | $10.94 | 4.69 |
| 2014-09-30 | 41.44 | $10.89 | 3.80 |
| 2014-06-30 | 43.50 | $10.70 | 4.07 |
| 2014-03-31 | 48.68 | $10.57 | 4.60 |
| 2013-12-31 | 47.90 | $10.74 | 4.46 |
| 2013-09-30 | 49.57 | $10.72 | 4.62 |
| 2013-06-30 | 45.06 | $10.88 | 4.14 |
| 2013-03-31 | 40.26 | $10.93 | 3.68 |
| 2012-12-31 | 29.61 | $11.22 | 2.64 |
| 2012-09-30 | 27.73 | $11.28 | 2.46 |
| 2012-06-30 | 27.17 | $11.43 | 2.38 |
| 2012-03-31 | 25.02 | $11.57 | 2.16 |
| 2011-12-31 | 21.55 | $10.39 | 2.07 |
| 2011-09-30 | 20.95 | $9.38 | 2.23 |
| 2011-06-30 | 20.58 | $8.13 | 2.53 |
| 2011-03-31 | 22.45 | $7.00 | 3.21 |
| 2010-12-31 | 20.70 | $6.90 | 3.00 |
| 2010-09-30 | 21.78 | $6.98 | 3.12 |
| 2010-06-30 | 18.40 | $7.11 | 2.59 |
| 2010-03-31 | 20.58 | $7.13 | 2.89 |
| 2009-12-31 | 21.28 | $7.15 | 2.98 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.211B | $0.050B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $196.826B | 25.11 |
| Stryker (SYK) | United States | $146.166B | 32.94 |
| Boston Scientific (BSX) | United States | $145.408B | 41.81 |
| EssilorLuxottica (ESLOY) | France | $115.383B | 0.00 |
| Medtronic (MDT) | Ireland | $112.944B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.849B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.827B | 27.18 |
| GE HealthCare Technologies (GEHC) | United States | $38.715B | 20.08 |
| ResMed (RMD) | United States | $35.199B | 28.92 |
| Terumo (TRUMY) | Japan | $27.980B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.250B | 18.56 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.811B | 13.89 |
| Insulet (PODD) | United States | $19.347B | 77.04 |
| Baxter (BAX) | United States | $15.818B | 10.29 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.057B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.586B | 32.58 |
| BellRing Brands (BRBR) | United States | $9.323B | 37.51 |
| Demant (WILYY) | Denmark | $8.735B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.360B | 14.78 |
| ICU Medical (ICUI) | United States | $4.012B | 38.20 |
| Prestige Consumer Healthcare (PBH) | United States | $3.882B | 19.31 |
| Haemonetics (HAE) | United States | $3.691B | 18.01 |
| Envista Holdings (NVST) | United States | $3.413B | 25.42 |
| Perrigo (PRGO) | Ireland | $3.252B | 9.57 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.807B | 18.07 |
| GN Store Nord (GNNDY) | Denmark | $2.585B | 16.58 |
| Neogen (NEOG) | United States | $2.508B | 28.90 |
| LeMaitre Vascular (LMAT) | United States | $2.227B | 54.13 |
| AtriCure (ATRC) | United States | $1.876B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.572B | 27.52 |
| AdaptHealth (AHCO) | United States | $1.416B | 10.11 |
| InMode (INMD) | Israel | $1.410B | 8.48 |
| BioLife Solutions (BLFS) | United States | $1.213B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.205B | 0.00 |
| Owens & Minor (OMI) | United States | $1.124B | 8.78 |
| Curaleaf Holdings (CURLF) | Canada | $0.981B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.843B | 14.87 |
| CeriBell (CBLL) | United States | $0.754B | 0.00 |
| Evolus (EOLS) | United States | $0.666B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.623B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.557B | 24.58 |
| Omeros (OMER) | United States | $0.541B | 0.00 |
| Surmodics (SRDX) | United States | $0.527B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.434B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.434B | 0.00 |
| ZimVie (ZIMV) | United States | $0.394B | 33.23 |
| Valneva SE (VALN) | France | $0.355B | 0.00 |
| Quanterix (QTRX) | United States | $0.342B | 0.00 |
| Cerus (CERS) | United States | $0.332B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.18 |
| Biote (BTMD) | United States | $0.306B | 6.71 |
| Sanara MedTech (SMTI) | United States | $0.285B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.272B | 18.25 |
| High Tide (HITI) | Canada | $0.250B | 103.00 |
| Zynex (ZYXI) | United States | $0.245B | 51.20 |
| Canopy Growth (CGC) | Canada | $0.237B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.226B | 3.18 |
| Aurora Cannabis (ACB) | Canada | $0.211B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
| Brainsway (BWAY) | Israel | $0.192B | 102.30 |
| MacroGenics (MGNX) | United States | $0.188B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.168B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.77 |
| Veru (VERU) | United States | $0.143B | 0.00 |
| Jin Medical (ZJYL) | China | $0.143B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.87 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| INLIF (INLF) | $0.078B | 0.00 | |
| InterCure (INCR) | Israel | $0.077B | 0.00 |
| Exagen (XGN) | United States | $0.070B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.069B | 35.33 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 14.11 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |